Detalhe da pesquisa
1.
Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction.
Arterioscler Thromb Vasc Biol
; 40(7): 1722-1737, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32404007
2.
Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction.
Circulation
; 133(15): 1484-97; discussion 1497, 2016 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-26933083
3.
Role of M2-like macrophage recruitment during angiogenic growth factor therapy.
Angiogenesis
; 18(2): 191-200, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25537851
4.
Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
FASEB J
; 28(8): 3351-61, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24760754
5.
Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
Arterioscler Thromb Vasc Biol
; 34(5): 1032-44, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24578383
6.
Selective Heart Rate Reduction Improves Metabolic Syndrome-related Left Ventricular Diastolic Dysfunction.
J Cardiovasc Pharmacol
; 66(4): 399-408, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26222991
7.
Circulating plasma serine208-phosphorylated troponin T levels are indicator of cardiac dysfunction.
J Cell Mol Med
; 17(10): 1335-44, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23905701
8.
Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MI.
Nat Commun
; 14(1): 4461, 2023 07 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37491334
9.
Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure.
Cardiovasc Res
; 119(2): 492-505, 2023 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-35689481
10.
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury.
J Adv Res
; 43: 163-174, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36585106
11.
Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
J Mol Cell Cardiol
; 52(6): 1257-64, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22446161
12.
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.
Circulation
; 124(9): 1059-69, 2011 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-21824923
13.
Progenitor cell mobilizing treatments prevent experimental transplant arteriosclerosis.
J Surg Res
; 176(2): 657-65, 2012 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-22341036
14.
Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
J Cardiovasc Pharmacol
; 59(3): 260-7, 2012 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-22075752
15.
Decreased serine207 phosphorylation of troponin T as a biomarker for left ventricular remodelling after myocardial infarction.
Eur Heart J
; 32(1): 115-23, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20418543
16.
Endothelial estrogen receptor {alpha} plays an essential role in the coronary and myocardial protective effects of estradiol in ischemia/reperfusion.
Arterioscler Thromb Vasc Biol
; 30(12): 2562-7, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20847304
17.
Brain death provokes very acute alteration in myocardial morphology detected by echocardiography: preventive effect of beta-blockers.
Transpl Int
; 24(3): 300-6, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21083628
18.
Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice.
ESC Heart Fail
; 8(3): 1933-1943, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33742556
19.
Transient heart rate reduction improves acute decompensated heart failure-induced left ventricular and coronary dysfunction.
ESC Heart Fail
; 8(2): 1085-1095, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33471946
20.
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
Eur Heart J
; 29(17): 2171-9, 2008 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-18586661